FOXM1 and cancer: Accordingly, there is high interest in FOXM1 as a cancer therapeutic target (Tabatabaei Dakhili et al., 2019; Halasi and Gartel, 2013b; Gormally et al., 2014; Ziegler et al., 2019; Xiang et al., 2017).